National Cancer Institute-ko ikertzaileekin lankidetzan egindako argitalpenak (20)

2024

  1. Genetically inferred birthweight, height, and puberty timing and risk of osteosarcoma

    Cancer Epidemiology, Vol. 92

2023

  1. Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

    Cancer Discovery, Vol. 13, Núm. 11, pp. 2370-2393

  2. Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial

    Nature Medicine, Vol. 29, Núm. 6, pp. 1370-1378

2020

  1. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients with Osteosarcoma

    JAMA Oncology, Vol. 6, Núm. 5, pp. 724-734

  2. Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma

    PLoS ONE, Vol. 15, Núm. 9 September

2018

  1. Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility

    Nature Communications, Vol. 9, Núm. 1

  2. Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients

    International Journal of Cancer, Vol. 142, Núm. 8, pp. 1594-1601

  3. Heterogeneity within the PF-EPN-B ependymoma subgroup

    Acta Neuropathologica, Vol. 136, Núm. 2, pp. 227-237

2016

  1. Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome

    Nature Communications, Vol. 7

  2. Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: A retrospective multicohort analysis

    Journal of Clinical Oncology, Vol. 34, Núm. 21, pp. 2468-2477

2015

  1. A genome-wide scan identifies variants in NFIB associated with metastasis in patients with osteosarcoma

    Cancer Discovery, Vol. 5, Núm. 9, pp. 920-931

  2. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

    Journal of the National Cancer Institute, Vol. 107, Núm. 12

  3. Characterization of large structural genetic mosaicism in human autosomes

    American Journal of Human Genetics, Vol. 96, Núm. 3, pp. 487-497

  4. Functionally defined therapeutic targets in diffuse intrinsic pontine glioma

    Nature Medicine, Vol. 21, Núm. 6, pp. 555-559

  5. Germline TP53 Variants and Susceptibility to Osteosarcoma

    Journal of the National Cancer Institute, Vol. 107, Núm. 7

2014

  1. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

    Human Molecular Genetics, Vol. 23, Núm. 24, pp. 6616-6633

2013

  1. Genome-wide association study identifies two susceptibility loci for osteosarcoma

    Nature Genetics, Vol. 45, Núm. 7, pp. 799-803

2012

  1. Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma

    Nature Genetics, Vol. 44, Núm. 3, pp. 323-327

  2. Detectable clonal mosaicism and its relationship to aging and cancer

    Nature Genetics, Vol. 44, Núm. 6, pp. 651-658

2011

  1. Height at diagnosis and birth-weight as risk factors for osteosarcoma

    Cancer Causes and Control, Vol. 22, Núm. 6, pp. 899-908